Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure
Appointed director
CC transcript
Appointed COO

KERYX BIOPHARMACEUTICALS INC (KERX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/26/2020 CT ORDER Form CT ORDER - Confidential treatment order:
12/26/2018 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/24/2018 EFFECT Form EFFECT - Notice of Effectiveness:
12/13/2018 4 ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 30,000 shares @ $0
Disposed/sold 140,000 options @ $0
12/13/2018 4 Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 10,000 shares @ $0
Disposed/sold 80,000 options @ $0
12/13/2018 4 Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 162,956 shares @ $0
Disposed/sold 902,500 options @ $0
12/13/2018 4 Morrison Jodie Pope (Interim CEO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 120,000 shares @ $0
Disposed/sold 110,000 options @ $0
12/13/2018 4 Regan Daniel Paul (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 60,000 shares @ $0
Disposed/sold 200,000 options @ $0
12/13/2018 4 Heffernan Michael Thomas (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 20,000 shares @ $0
Disposed/sold 110,000 options @ $0
12/13/2018 4 GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 27,333 shares @ $0
Disposed/sold 140,000 options @ $0
12/13/2018 4 Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 148,279 shares @ $0
Disposed/sold 772,500 options @ $0
12/13/2018 4 Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Disposed/sold 186,666 shares @ $0
Disposed/sold 290,000 options @ $0
12/13/2018 4 Carberry Christine A. (COO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 10,469 shares @ $3.22, valued at $33.7k
Disposed/sold 100,646 shares @ $0
Disposed/sold 422,500 options @ $0
12/13/2018 4 BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 35,582,335 shares @ $4.63, valued at $164.7M
Granted 4,000,000 shares @ $0
Disposed/sold 65,374,013 shares @ $0
Exercised options to buy @ $4.63, valued at $0
12/13/2018 SC 13D/A Baupost Group reports a 0% stake in Keryx Biopharmaceuticals, Inc.
12/13/2018 POS462B Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]:
12/13/2018 POS462B Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]:
12/13/2018 POS462B Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]:
12/13/2018 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy